BSEM News and Press, BioStem Technologies Inc From 12/14/22

Kill Cliff FC is One of the world’s largest MMA Training Centers with More T han 80 P rofessional F ighters POMPANO BEACH, FLORIDA., Dec. 14, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading re...

BioStem Technologies press release ( OTCPK:BSEM ): Q3 GAAP EPS of -$0.14. Revenue of $1.15M misses by $1.05M . For further details see: BioStem Technologies GAAP EPS of -$0.14, revenue of $1.15M misses by $1.05M

Company to Host a Conference Call and Webcast on November 15 , 2022, at 4:30 pm EDT POMPANO BEACH, FLORIDA., Nov. 15, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commerci...

POMPANO BEACH, FLORIDA., Nov. 15, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today announced it will host a conference call to discuss ...

Medicine company BioStem Technologies ( OTCPK:BSEM ) promoted Michael Fortunato to the position of CFO from the role of controller, effective immediately. Fortunato has over 28 years of expert level financial accounting, SEC reporting, M&A and IPO experience. ...

POMPANO BEACH, FLORIDA., Oct. 26, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (“BioStem” or the “Company) (OTC PINK: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived tissue allograf...

POMPANO BEACH, FLORIDA., Oct. 10, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC PINK: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived tissue allografts, today announced that Jason Matuszewski, Chief...

Standardi zed methodology demonstrates high presence of placental membrane growth factors in BioStem’s Vendaje ® and Vendaje AC ® tissue allografts POMPANO BEACH, FLORIDA., Sept. 13, 2022 (GLOBE NEWSWIR...

POMPANO BEACH, FLORIDA., Sept. 08, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived tissue allografts, today announced the appointment of Brandon Poe as...

BioStem Technologies press release ( OTCPK:BSEM ): Q2 GAAP EPS of -$0.02. Revenue of $2.16M (+132.3% Y/Y). For further details see: BioStem Technologies GAAP EPS of -$0.02, revenue of $2.16M